Met Life Investment Management, LLC Humanigen, Inc Transaction History

Met Life Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.66 - $8.22 $66,586 - $149,546	-18,193 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$5.93 - $17.83 $107,884 - $324,381	18,193 New	18,193 $107,000
Q2 2021 May 17, 2024	BUY	$13.54 - $22.74 $246,333 - $413,708	18,193 New	18,193 $316,000
Q2 2021 Jun 21, 2023	BUY	$13.54 - $22.74 $246,333 - $413,708	18,193 New	18,193 $316,000
Q2 2021 Mar 22, 2023	BUY	$13.54 - $22.74 $246,333 - $413,708	18,193 New	18,193 $316,000
Q2 2021 Aug 16, 2021	BUY	$13.54 - $22.74 $246,333 - $413,708	18,193 New	18,193 $316,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.